Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
kalamanova a
(2 results)?
Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Int J Gynecol Cancer. 2023 Jun 5;33(6):897-904. doi: 10.1136/ijgc-2022-004204.
Int J Gynecol Cancer. 2023.
PMID: 37192761
Impact of Hospital Case Volume on Uterine Sarcoma Prognosis: SARCUT Study Subanalysis.
Gorostidi M, Yildirim Y, Macuks R, Mancari R, Achimas-Cadariu P, Ibañez E, Corrado G, Bartusevicius A, Sukhina O, Zapardiel I; SARCUT Study Group.
Gorostidi M, et al.
Ann Surg Oncol. 2023 Nov;30(12):7645-7652. doi: 10.1245/s10434-023-13826-4. Epub 2023 Jul 17.
Ann Surg Oncol. 2023.
PMID: 37460742
Item in Clipboard
Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma.
Bharathan R, Polterauer S, Lopez-Sanclemente MC, Trukhan H, Pletnev A, Heredia AG, Gil MM, Bakinovskaya I, Dalamanava A, Romeo M, Rovski D, Baquedano L, Chiva L, Schwameis R, Zapardiel I, On Behalf Of Sarcut Study Group.
Bharathan R, et al. Among authors: dalamanava a.
J Pers Med. 2024 Jan 30;14(2):155. doi: 10.3390/jpm14020155.
J Pers Med. 2024.
PMID: 38392588
Free PMC article.
Item in Clipboard
Cite
Cite